Pharma & Healthcare
Global Amifostine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 297957
- Pages: 133
- Figures: 136
- Views: 41
In 2024, the global market size of Amifostine was estimated to be worth US$ 52.1 million and is forecast to reach approximately US$ 60.1 million by 2031 with a CAGR of 2.1% during the forecast period 2025-2031.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amifostine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifostine.
The Amifostine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amifostine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amifostine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Segment by Type
400mg/Dose
500mg/Dose
Segment by Application
Head and Neck Cancer Adjuvant Therapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Amifostine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amifostine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.
Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amifostine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifostine.
The Amifostine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amifostine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amifostine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Segment by Type
400mg/Dose
500mg/Dose
Segment by Application
Head and Neck Cancer Adjuvant Therapy
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Amifostine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amifostine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Amifostine Product Introduction
1.2 Market by Type
1.2.1 Global Amifostine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 400mg/Dose
1.2.3 500mg/Dose
1.3 Market by Application
1.3.1 Global Amifostine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amifostine Market Size Estimates and Forecasts
2.1.1 Global Amifostine Revenue 2020-2031
2.1.2 Global Amifostine Sales 2020-2031
2.2 Amifostine Market Size by Region: 2024 Versus 2031
2.3 Amifostine Sales by Region (2020-2031)
2.3.1 Global Amifostine Sales by Region: 2020-2025
2.3.2 Global Amifostine Sales Forecast by Region (2026-2031)
2.3.3 Global Amifostine Sales Market Share by Region (2020-2031)
2.4 Amifostine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Amifostine Revenue by Region: 2020-2025
2.4.2 Global Amifostine Revenue Forecast by Region (2026-2031)
2.4.3 Global Amifostine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Amifostine Sales by Type (2020-2031)
3.1.1.1 Global Amifostine Sales Volume by Type (2020-2031)
3.1.1.2 Global Amifostine Sales Market Share by Type (2020-2031)
3.1.2 Global Amifostine Revenue by Type (2020-2031)
3.1.2.1 Global Amifostine Revenue by Type (2020-2031)
3.1.2.2 Global Amifostine Revenue Market Share by Type (2020-2031)
3.1.3 Amifostine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Amifostine Sales by Application (2020-2031)
3.2.1.1 Global Amifostine Sales Volume by Application (2020-2031)
3.2.1.2 Global Amifostine Sales Market Share by Application (2020-2031)
3.2.2 Global Amifostine Revenue by Application (2020-2031)
3.2.2.1 Global Amifostine Revenue by Application (2020-2031)
3.2.2.2 Global Amifostine Revenue Market Share by Application (2020-2031)
3.2.3 Amifostine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 400mg/Dose of Amifostine Revenue Market Share by Application
3.3.2 500mg/Dose of Amifostine Revenue Market Share by Application
4 Global Amifostine by Manufacturers
4.1 Global Top Amifostine Manufacturers by Sales (2020-2025)
4.1.1 Global Amifostine Sales by Manufacturer (2020-2025)
4.1.2 Global Amifostine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Amifostine Manufacturers by Revenue (2020-2025)
4.2.1 Global Amifostine Revenue by Manufacturer (2020-2025)
4.2.2 Global Amifostine Revenue Share by Manufacturer (2020-2025)
4.3 Global Amifostine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Amifostine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Amifostine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Amifostine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Amifostine Manufacturing Base Distribution, Product Type
4.5.1 Amifostine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Amifostine Market
4.5.3 Manufacturers Amifostine Product Type and Application
4.5.4 400mg/Dose Market Sales of Amifostine by Manufacturer
4.5.5 500mg/Dose Market Sales of Amifostine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Clinigen
5.1.1 Clinigen Company Information
5.1.2 Clinigen Description, Business Overview
5.1.3 Clinigen Amifostine Products Offered
5.1.4 Clinigen Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Clinigen Amifostine Sales by Product in 2024
5.1.6 Clinigen Amifostine Sales by Application in 2024
5.1.7 Clinigen Amifostine Sales by Geographic Area in 2024
5.1.8 Clinigen Recent Developments
5.2 Sun Pharmaceutical
5.2.1 Sun Pharmaceutical Company Information
5.2.2 Sun Pharmaceutical Description, Business Overview
5.2.3 Sun Pharmaceutical Amifostine Products Offered
5.2.4 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sun Pharmaceutical Amifostine Sales by Product in 2024
5.2.6 Sun Pharmaceutical Amifostine Sales by Application in 2024
5.2.7 Sun Pharmaceutical Amifostine Sales by Geographic Area in 2024
5.2.8 Sun Pharmaceutical Recent Developments
5.3 Taj Pharmaceuticals
5.3.1 Taj Pharmaceuticals Company Information
5.3.2 Taj Pharmaceuticals Description, Business Overview
5.3.3 Taj Pharmaceuticals Amifostine Products Offered
5.3.4 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Taj Pharmaceuticals Amifostine Sales by Product in 2024
5.3.6 Taj Pharmaceuticals Amifostine Sales by Application in 2024
5.3.7 Taj Pharmaceuticals Amifostine Sales by Geographic Area in 2024
5.3.8 Taj Pharmaceuticals Recent Developments
5.4 Merro Pharmaceutical
5.4.1 Merro Pharmaceutical Company Information
5.4.2 Merro Pharmaceutical Description, Business Overview
5.4.3 Merro Pharmaceutical Amifostine Products Offered
5.4.4 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Merro Pharmaceutical Amifostine Sales by Product in 2024
5.4.6 Merro Pharmaceutical Amifostine Sales by Application in 2024
5.4.7 Merro Pharmaceutical Amifostine Sales by Geographic Area in 2024
5.4.8 Merro Pharmaceutical Recent Developments
5.5 Luye Pharma
5.5.1 Luye Pharma Company Information
5.5.2 Luye Pharma Description, Business Overview
5.5.3 Luye Pharma Amifostine Products Offered
5.5.4 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Luye Pharma Amifostine Sales by Product in 2024
5.5.6 Luye Pharma Amifostine Sales by Application in 2024
5.5.7 Luye Pharma Amifostine Sales by Geographic Area in 2024
5.5.8 Luye Pharma Recent Developments
5.6 Mingren Pharma
5.6.1 Mingren Pharma Company Information
5.6.2 Mingren Pharma Description, Business Overview
5.6.3 Mingren Pharma Amifostine Products Offered
5.6.4 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Mingren Pharma Amifostine Sales by Product in 2024
5.6.6 Mingren Pharma Amifostine Sales by Application in 2024
5.6.7 Mingren Pharma Amifostine Sales by Geographic Area in 2024
5.6.8 Mingren Pharma Recent Developments
6 North America
6.1 North America Amifostine Market Size YoY Growth 2020-2031
6.2 North America Amifostine Market Facts & Figures by Country
6.2.1 North America Amifostine Sales by Country (2020-2031)
6.2.2 North America Amifostine Revenue by Country (2020-2031)
6.3 North America Amifostine Sales by Type (2020-2025)
6.4 North America Amifostine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Amifostine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Amifostine Market Facts & Figures by Region
7.2.1 Asia-Pacific Amifostine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Amifostine Revenue by Region (2020-2031)
7.3 Asia-Pacific Amifostine Sales by Type (2020-2025)
7.4 Asia-Pacific Amifostine Sales by Application (2020-2025)
8 Europe
8.1 Europe Amifostine Market Size YoY Growth 2020-2031
8.2 Europe Amifostine Market Facts & Figures by Country
8.2.1 Europe Amifostine Sales by Country (2020-2031)
8.2.2 Europe Amifostine Revenue by Country (2020-2031)
8.3 Europe Amifostine Sales by Type (2020-2025)
8.4 Europe Amifostine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Amifostine Market Size YoY Growth 2020-2031
9.2 Latin America Amifostine Market Facts & Figures by Country
9.2.1 Latin America Amifostine Sales by Country (2020-2031)
9.2.2 Latin America Amifostine Revenue by Country (2020-2031)
9.3 Latin America Amifostine Sales by Type (2020-2025)
9.4 Latin America Amifostine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Amifostine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Amifostine Market Facts & Figures by Country
10.2.1 Middle East and Africa Amifostine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Amifostine Revenue by Country (2020-2031)
10.3 Middle East and Africa Amifostine Sales by Type (2020-2025)
10.4 Middle East and Africa Amifostine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Amifostine Supply Chain Analysis
11.2 Amifostine Key Raw Materials and Upstream Suppliers
11.3 Amifostine Clients Analysis
11.4 Amifostine Sales Channel and Sales Model Analysis
11.4.1 Amifostine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Amifostine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Amifostine Distributors
12 Amifostine Market Dynamics
12.1 Amifostine Industry Trends
12.2 Amifostine Market Drivers
12.3 Amifostine Market Challenges
12.4 Amifostine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Amifostine Product Introduction
1.2 Market by Type
1.2.1 Global Amifostine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 400mg/Dose
1.2.3 500mg/Dose
1.3 Market by Application
1.3.1 Global Amifostine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Head and Neck Cancer Adjuvant Therapy
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amifostine Market Size Estimates and Forecasts
2.1.1 Global Amifostine Revenue 2020-2031
2.1.2 Global Amifostine Sales 2020-2031
2.2 Amifostine Market Size by Region: 2024 Versus 2031
2.3 Amifostine Sales by Region (2020-2031)
2.3.1 Global Amifostine Sales by Region: 2020-2025
2.3.2 Global Amifostine Sales Forecast by Region (2026-2031)
2.3.3 Global Amifostine Sales Market Share by Region (2020-2031)
2.4 Amifostine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Amifostine Revenue by Region: 2020-2025
2.4.2 Global Amifostine Revenue Forecast by Region (2026-2031)
2.4.3 Global Amifostine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Amifostine Sales by Type (2020-2031)
3.1.1.1 Global Amifostine Sales Volume by Type (2020-2031)
3.1.1.2 Global Amifostine Sales Market Share by Type (2020-2031)
3.1.2 Global Amifostine Revenue by Type (2020-2031)
3.1.2.1 Global Amifostine Revenue by Type (2020-2031)
3.1.2.2 Global Amifostine Revenue Market Share by Type (2020-2031)
3.1.3 Amifostine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Amifostine Sales by Application (2020-2031)
3.2.1.1 Global Amifostine Sales Volume by Application (2020-2031)
3.2.1.2 Global Amifostine Sales Market Share by Application (2020-2031)
3.2.2 Global Amifostine Revenue by Application (2020-2031)
3.2.2.1 Global Amifostine Revenue by Application (2020-2031)
3.2.2.2 Global Amifostine Revenue Market Share by Application (2020-2031)
3.2.3 Amifostine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 400mg/Dose of Amifostine Revenue Market Share by Application
3.3.2 500mg/Dose of Amifostine Revenue Market Share by Application
4 Global Amifostine by Manufacturers
4.1 Global Top Amifostine Manufacturers by Sales (2020-2025)
4.1.1 Global Amifostine Sales by Manufacturer (2020-2025)
4.1.2 Global Amifostine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Amifostine Manufacturers by Revenue (2020-2025)
4.2.1 Global Amifostine Revenue by Manufacturer (2020-2025)
4.2.2 Global Amifostine Revenue Share by Manufacturer (2020-2025)
4.3 Global Amifostine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Amifostine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Amifostine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Amifostine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Amifostine Manufacturing Base Distribution, Product Type
4.5.1 Amifostine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Amifostine Market
4.5.3 Manufacturers Amifostine Product Type and Application
4.5.4 400mg/Dose Market Sales of Amifostine by Manufacturer
4.5.5 500mg/Dose Market Sales of Amifostine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Clinigen
5.1.1 Clinigen Company Information
5.1.2 Clinigen Description, Business Overview
5.1.3 Clinigen Amifostine Products Offered
5.1.4 Clinigen Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Clinigen Amifostine Sales by Product in 2024
5.1.6 Clinigen Amifostine Sales by Application in 2024
5.1.7 Clinigen Amifostine Sales by Geographic Area in 2024
5.1.8 Clinigen Recent Developments
5.2 Sun Pharmaceutical
5.2.1 Sun Pharmaceutical Company Information
5.2.2 Sun Pharmaceutical Description, Business Overview
5.2.3 Sun Pharmaceutical Amifostine Products Offered
5.2.4 Sun Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Sun Pharmaceutical Amifostine Sales by Product in 2024
5.2.6 Sun Pharmaceutical Amifostine Sales by Application in 2024
5.2.7 Sun Pharmaceutical Amifostine Sales by Geographic Area in 2024
5.2.8 Sun Pharmaceutical Recent Developments
5.3 Taj Pharmaceuticals
5.3.1 Taj Pharmaceuticals Company Information
5.3.2 Taj Pharmaceuticals Description, Business Overview
5.3.3 Taj Pharmaceuticals Amifostine Products Offered
5.3.4 Taj Pharmaceuticals Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Taj Pharmaceuticals Amifostine Sales by Product in 2024
5.3.6 Taj Pharmaceuticals Amifostine Sales by Application in 2024
5.3.7 Taj Pharmaceuticals Amifostine Sales by Geographic Area in 2024
5.3.8 Taj Pharmaceuticals Recent Developments
5.4 Merro Pharmaceutical
5.4.1 Merro Pharmaceutical Company Information
5.4.2 Merro Pharmaceutical Description, Business Overview
5.4.3 Merro Pharmaceutical Amifostine Products Offered
5.4.4 Merro Pharmaceutical Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Merro Pharmaceutical Amifostine Sales by Product in 2024
5.4.6 Merro Pharmaceutical Amifostine Sales by Application in 2024
5.4.7 Merro Pharmaceutical Amifostine Sales by Geographic Area in 2024
5.4.8 Merro Pharmaceutical Recent Developments
5.5 Luye Pharma
5.5.1 Luye Pharma Company Information
5.5.2 Luye Pharma Description, Business Overview
5.5.3 Luye Pharma Amifostine Products Offered
5.5.4 Luye Pharma Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Luye Pharma Amifostine Sales by Product in 2024
5.5.6 Luye Pharma Amifostine Sales by Application in 2024
5.5.7 Luye Pharma Amifostine Sales by Geographic Area in 2024
5.5.8 Luye Pharma Recent Developments
5.6 Mingren Pharma
5.6.1 Mingren Pharma Company Information
5.6.2 Mingren Pharma Description, Business Overview
5.6.3 Mingren Pharma Amifostine Products Offered
5.6.4 Mingren Pharma Amifostine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Mingren Pharma Amifostine Sales by Product in 2024
5.6.6 Mingren Pharma Amifostine Sales by Application in 2024
5.6.7 Mingren Pharma Amifostine Sales by Geographic Area in 2024
5.6.8 Mingren Pharma Recent Developments
6 North America
6.1 North America Amifostine Market Size YoY Growth 2020-2031
6.2 North America Amifostine Market Facts & Figures by Country
6.2.1 North America Amifostine Sales by Country (2020-2031)
6.2.2 North America Amifostine Revenue by Country (2020-2031)
6.3 North America Amifostine Sales by Type (2020-2025)
6.4 North America Amifostine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Amifostine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Amifostine Market Facts & Figures by Region
7.2.1 Asia-Pacific Amifostine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Amifostine Revenue by Region (2020-2031)
7.3 Asia-Pacific Amifostine Sales by Type (2020-2025)
7.4 Asia-Pacific Amifostine Sales by Application (2020-2025)
8 Europe
8.1 Europe Amifostine Market Size YoY Growth 2020-2031
8.2 Europe Amifostine Market Facts & Figures by Country
8.2.1 Europe Amifostine Sales by Country (2020-2031)
8.2.2 Europe Amifostine Revenue by Country (2020-2031)
8.3 Europe Amifostine Sales by Type (2020-2025)
8.4 Europe Amifostine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Amifostine Market Size YoY Growth 2020-2031
9.2 Latin America Amifostine Market Facts & Figures by Country
9.2.1 Latin America Amifostine Sales by Country (2020-2031)
9.2.2 Latin America Amifostine Revenue by Country (2020-2031)
9.3 Latin America Amifostine Sales by Type (2020-2025)
9.4 Latin America Amifostine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Amifostine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Amifostine Market Facts & Figures by Country
10.2.1 Middle East and Africa Amifostine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Amifostine Revenue by Country (2020-2031)
10.3 Middle East and Africa Amifostine Sales by Type (2020-2025)
10.4 Middle East and Africa Amifostine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Amifostine Supply Chain Analysis
11.2 Amifostine Key Raw Materials and Upstream Suppliers
11.3 Amifostine Clients Analysis
11.4 Amifostine Sales Channel and Sales Model Analysis
11.4.1 Amifostine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Amifostine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Amifostine Distributors
12 Amifostine Market Dynamics
12.1 Amifostine Industry Trends
12.2 Amifostine Market Drivers
12.3 Amifostine Market Challenges
12.4 Amifostine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Amifostine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Amifostine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Amifostine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Amifostine Sales by Region (2020-2025) & (K Units)
Table 5. Global Amifostine Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Amifostine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Amifostine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Amifostine Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Amifostine Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Amifostine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Amifostine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Amifostine Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Amifostine Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Amifostine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Amifostine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Amifostine Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Amifostine Sales Share by Manufacturer (2020-2025)
Table 18. Amifostine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Amifostine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Amifostine Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Amifostine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Amifostine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Amifostine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifostine as of 2024)
Table 24. Amifostine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Amifostine Market
Table 26. Manufacturers Amifostine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Clinigen Company Information
Table 29. Clinigen Description and Business Overview
Table 30. Clinigen Amifostine Product
Table 31. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Clinigen Sales Proportion of Amifostine by Product in 2024
Table 33. Clinigen Sales Proportion of Amifostine by Application in 2024
Table 34. Clinigen Sales Proportion of Amifostine by Geographic Area in 2024
Table 35. Clinigen Recent Developments
Table 36. Sun Pharmaceutical Company Information
Table 37. Sun Pharmaceutical Description and Business Overview
Table 38. Sun Pharmaceutical Amifostine Product
Table 39. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Sun Pharmaceutical Sales Proportion of Amifostine by Product in 2024
Table 41. Sun Pharmaceutical Sales Proportion of Amifostine by Application in 2024
Table 42. Sun Pharmaceutical Sales Proportion of Amifostine by Geographic Area in 2024
Table 43. Sun Pharmaceutical Recent Developments
Table 44. Taj Pharmaceuticals Company Information
Table 45. Taj Pharmaceuticals Description and Business Overview
Table 46. Taj Pharmaceuticals Amifostine Product
Table 47. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Taj Pharmaceuticals Sales Proportion of Amifostine by Product in 2024
Table 49. Taj Pharmaceuticals Sales Proportion of Amifostine by Application in 2024
Table 50. Taj Pharmaceuticals Sales Proportion of Amifostine by Geographic Area in 2024
Table 51. Taj Pharmaceuticals Recent Developments
Table 52. Merro Pharmaceutical Company Information
Table 53. Merro Pharmaceutical Description and Business Overview
Table 54. Merro Pharmaceutical Amifostine Product
Table 55. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Merro Pharmaceutical Sales Proportion of Amifostine by Product in 2024
Table 57. Merro Pharmaceutical Sales Proportion of Amifostine by Application in 2024
Table 58. Merro Pharmaceutical Sales Proportion of Amifostine by Geographic Area in 2024
Table 59. Merro Pharmaceutical Recent Developments
Table 60. Luye Pharma Company Information
Table 61. Luye Pharma Description and Business Overview
Table 62. Luye Pharma Amifostine Product
Table 63. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Luye Pharma Sales Proportion of Amifostine by Product in 2024
Table 65. Luye Pharma Sales Proportion of Amifostine by Application in 2024
Table 66. Luye Pharma Sales Proportion of Amifostine by Geographic Area in 2024
Table 67. Luye Pharma Recent Developments
Table 68. Mingren Pharma Company Information
Table 69. Mingren Pharma Description and Business Overview
Table 70. Mingren Pharma Amifostine Product
Table 71. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Mingren Pharma Sales Proportion of Amifostine by Product in 2024
Table 73. Mingren Pharma Sales Proportion of Amifostine by Application in 2024
Table 74. Mingren Pharma Sales Proportion of Amifostine by Geographic Area in 2024
Table 75. Mingren Pharma Recent Developments
Table 76. North America Amifostine Sales by Country (2020-2025) & (K Units)
Table 77. North America Amifostine Sales by Country (2026-2031) & (K Units)
Table 78. North America Amifostine Revenue by Country (2020-2025) & (US$ Million)
Table 79. North America Amifostine Revenue by Country (2026-2031) & (US$ Million)
Table 80. North America Amifostine Sales by Type (2020-2025) & (K Units)
Table 81. North America Amifostine Sales by Application (2020-2025) & (K Units)
Table 82. Asia-Pacific Amifostine Sales by Region (2020-2025) & (K Units)
Table 83. Asia-Pacific Amifostine Sales by Region (2026-2031) & (K Units)
Table 84. Asia-Pacific Amifostine Revenue by Region (2020-2025) & (US$ Million)
Table 85. Asia-Pacific Amifostine Revenue by Region (2026-2031) & (US$ Million)
Table 86. Asia-Pacific Amifostine Sales by Type (2020-2025) & (K Units)
Table 87. Asia-Pacific Amifostine Sales by Application (2020-2025) & (K Units)
Table 88. Europe Amifostine Sales by Country (2020-2025) & (K Units)
Table 89. Europe Amifostine Sales by Country (2026-2031) & (K Units)
Table 90. Europe Amifostine Revenue by Country (2020-2025) & (US$ Million)
Table 91. Europe Amifostine Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Amifostine Sales by Type (2020-2025) & (K Units)
Table 93. Europe Amifostine Sales by Application (2020-2025) & (K Units)
Table 94. Latin America Amifostine Sales by Country (2020-2025) & (K Units)
Table 95. Latin America Amifostine Sales by Country (2026-2031) & (K Units)
Table 96. Latin America Amifostine Revenue by Country (2020-2025) & (US$ Million)
Table 97. Latin America Amifostine Revenue by Country (2026-2031) & (US$ Million)
Table 98. Latin America Amifostine Sales by Type (2020-2025) & (K Units)
Table 99. Latin America Amifostine Sales by Application (2020-2025) & (K Units)
Table 100. Middle East and Africa Amifostine Sales by Country (2020-2025) & (K Units)
Table 101. Middle East and Africa Amifostine Sales by Country (2026-2031) & (K Units)
Table 102. Middle East and Africa Amifostine Revenue by Country (2020-2025) & (US$ Million)
Table 103. Middle East and Africa Amifostine Revenue by Country (2026-2031) & (US$ Million)
Table 104. Middle East and Africa Amifostine Sales by Type (2020-2025) & (K Units)
Table 105. Middle East and Africa Amifostine Sales by Application (2020-2025) & (K Units)
Table 106. Amifostine Key Raw Materials, Industry Status and Trend
Table 107. Amifostine Key Raw Materials and Upstream Suppliers
Table 108. Amifostine Clients Status and Trend
Table 109. Amifostine Typical Clients
Table 110. Amifostine Distributors
Table 111. Amifostine Market Trends
Table 112. Amifostine Market Drivers
Table 113. Amifostine Market Challenges
Table 114. Amifostine Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Amifostine Product Picture
Figure 2. Global Amifostine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Amifostine Sales Market Share by Type in 2024 & 2031
Figure 4. 400mg/Dose Product Picture
Figure 5. 500mg/Dose Product Picture
Figure 6. Global Amifostine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Amifostine Sales Market Share by Application in 2024 & 2031
Figure 8. Head and Neck Cancer Adjuvant Therapy
Figure 9. Others
Figure 10. Amifostine Report Years Considered
Figure 11. Global Amifostine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Amifostine Market Size 2020-2031 (US$ Million)
Figure 13. Global Amifostine Sales 2020-2031 (K Units)
Figure 14. Global Amifostine Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Amifostine Revenue Market Share by Region (2020-2031)
Figure 16. Global Amifostine Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Amifostine Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Amifostine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 19. Global Amifostine Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Amifostine Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Amifostine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 22. 400mg/Dose of Amifostine Revenue Market Share by Application, 2024 VS 2031
Figure 23. 500mg/Dose of Amifostine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Amifostine Sales Share by Manufacturer in 2024
Figure 25. Amifostine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. 400mg/Dose Market Sales Proportion by Manufacturer in 2024
Figure 27. 500mg/Dose Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Amifostine Revenue 2020-2031 (US$ Million)
Figure 29. North America Amifostine Sales Market Share by Type (2020-2025)
Figure 30. North America Amifostine Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Amifostine Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Amifostine Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Amifostine Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Amifostine Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Amifostine Sales Market Share by Application (2020-2025)
Figure 36. Europe Amifostine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Amifostine Sales Market Share by Country (2020-2031)
Figure 38. Europe Amifostine Revenue Market Share by Country (2020-2031)
Figure 39. Europe Amifostine Sales Market Share by Type (2020-2025)
Figure 40. Europe Amifostine Sales Market Share by Application (2020-2025)
Figure 41. Latin America Amifostine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Amifostine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Amifostine Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Amifostine Sales Market Share by Type (2020-2025)
Figure 45. Latin America Amifostine Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Amifostine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Amifostine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Amifostine Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Amifostine Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Amifostine Sales Market Share by Application (2020-2025)
Figure 51. Amifostine Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Amifostine Raw Materials by Region in 2024
Figure 53. Amifostine Distribution Channels
Figure 54. Global Amifostine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Amifostine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Amifostine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Amifostine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Amifostine Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Amifostine Sales by Region (2020-2025) & (K Units)
Table 5. Global Amifostine Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Amifostine Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Amifostine Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Amifostine Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Amifostine Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Amifostine Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Amifostine Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Amifostine Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Amifostine Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Amifostine Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Amifostine Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Amifostine Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Amifostine Sales Share by Manufacturer (2020-2025)
Table 18. Amifostine Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Amifostine Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Amifostine Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Amifostine Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Amifostine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Amifostine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifostine as of 2024)
Table 24. Amifostine Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Amifostine Market
Table 26. Manufacturers Amifostine Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Clinigen Company Information
Table 29. Clinigen Description and Business Overview
Table 30. Clinigen Amifostine Product
Table 31. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Clinigen Sales Proportion of Amifostine by Product in 2024
Table 33. Clinigen Sales Proportion of Amifostine by Application in 2024
Table 34. Clinigen Sales Proportion of Amifostine by Geographic Area in 2024
Table 35. Clinigen Recent Developments
Table 36. Sun Pharmaceutical Company Information
Table 37. Sun Pharmaceutical Description and Business Overview
Table 38. Sun Pharmaceutical Amifostine Product
Table 39. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Sun Pharmaceutical Sales Proportion of Amifostine by Product in 2024
Table 41. Sun Pharmaceutical Sales Proportion of Amifostine by Application in 2024
Table 42. Sun Pharmaceutical Sales Proportion of Amifostine by Geographic Area in 2024
Table 43. Sun Pharmaceutical Recent Developments
Table 44. Taj Pharmaceuticals Company Information
Table 45. Taj Pharmaceuticals Description and Business Overview
Table 46. Taj Pharmaceuticals Amifostine Product
Table 47. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. Taj Pharmaceuticals Sales Proportion of Amifostine by Product in 2024
Table 49. Taj Pharmaceuticals Sales Proportion of Amifostine by Application in 2024
Table 50. Taj Pharmaceuticals Sales Proportion of Amifostine by Geographic Area in 2024
Table 51. Taj Pharmaceuticals Recent Developments
Table 52. Merro Pharmaceutical Company Information
Table 53. Merro Pharmaceutical Description and Business Overview
Table 54. Merro Pharmaceutical Amifostine Product
Table 55. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. Merro Pharmaceutical Sales Proportion of Amifostine by Product in 2024
Table 57. Merro Pharmaceutical Sales Proportion of Amifostine by Application in 2024
Table 58. Merro Pharmaceutical Sales Proportion of Amifostine by Geographic Area in 2024
Table 59. Merro Pharmaceutical Recent Developments
Table 60. Luye Pharma Company Information
Table 61. Luye Pharma Description and Business Overview
Table 62. Luye Pharma Amifostine Product
Table 63. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Luye Pharma Sales Proportion of Amifostine by Product in 2024
Table 65. Luye Pharma Sales Proportion of Amifostine by Application in 2024
Table 66. Luye Pharma Sales Proportion of Amifostine by Geographic Area in 2024
Table 67. Luye Pharma Recent Developments
Table 68. Mingren Pharma Company Information
Table 69. Mingren Pharma Description and Business Overview
Table 70. Mingren Pharma Amifostine Product
Table 71. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Mingren Pharma Sales Proportion of Amifostine by Product in 2024
Table 73. Mingren Pharma Sales Proportion of Amifostine by Application in 2024
Table 74. Mingren Pharma Sales Proportion of Amifostine by Geographic Area in 2024
Table 75. Mingren Pharma Recent Developments
Table 76. North America Amifostine Sales by Country (2020-2025) & (K Units)
Table 77. North America Amifostine Sales by Country (2026-2031) & (K Units)
Table 78. North America Amifostine Revenue by Country (2020-2025) & (US$ Million)
Table 79. North America Amifostine Revenue by Country (2026-2031) & (US$ Million)
Table 80. North America Amifostine Sales by Type (2020-2025) & (K Units)
Table 81. North America Amifostine Sales by Application (2020-2025) & (K Units)
Table 82. Asia-Pacific Amifostine Sales by Region (2020-2025) & (K Units)
Table 83. Asia-Pacific Amifostine Sales by Region (2026-2031) & (K Units)
Table 84. Asia-Pacific Amifostine Revenue by Region (2020-2025) & (US$ Million)
Table 85. Asia-Pacific Amifostine Revenue by Region (2026-2031) & (US$ Million)
Table 86. Asia-Pacific Amifostine Sales by Type (2020-2025) & (K Units)
Table 87. Asia-Pacific Amifostine Sales by Application (2020-2025) & (K Units)
Table 88. Europe Amifostine Sales by Country (2020-2025) & (K Units)
Table 89. Europe Amifostine Sales by Country (2026-2031) & (K Units)
Table 90. Europe Amifostine Revenue by Country (2020-2025) & (US$ Million)
Table 91. Europe Amifostine Revenue by Country (2026-2031) & (US$ Million)
Table 92. Europe Amifostine Sales by Type (2020-2025) & (K Units)
Table 93. Europe Amifostine Sales by Application (2020-2025) & (K Units)
Table 94. Latin America Amifostine Sales by Country (2020-2025) & (K Units)
Table 95. Latin America Amifostine Sales by Country (2026-2031) & (K Units)
Table 96. Latin America Amifostine Revenue by Country (2020-2025) & (US$ Million)
Table 97. Latin America Amifostine Revenue by Country (2026-2031) & (US$ Million)
Table 98. Latin America Amifostine Sales by Type (2020-2025) & (K Units)
Table 99. Latin America Amifostine Sales by Application (2020-2025) & (K Units)
Table 100. Middle East and Africa Amifostine Sales by Country (2020-2025) & (K Units)
Table 101. Middle East and Africa Amifostine Sales by Country (2026-2031) & (K Units)
Table 102. Middle East and Africa Amifostine Revenue by Country (2020-2025) & (US$ Million)
Table 103. Middle East and Africa Amifostine Revenue by Country (2026-2031) & (US$ Million)
Table 104. Middle East and Africa Amifostine Sales by Type (2020-2025) & (K Units)
Table 105. Middle East and Africa Amifostine Sales by Application (2020-2025) & (K Units)
Table 106. Amifostine Key Raw Materials, Industry Status and Trend
Table 107. Amifostine Key Raw Materials and Upstream Suppliers
Table 108. Amifostine Clients Status and Trend
Table 109. Amifostine Typical Clients
Table 110. Amifostine Distributors
Table 111. Amifostine Market Trends
Table 112. Amifostine Market Drivers
Table 113. Amifostine Market Challenges
Table 114. Amifostine Market Restraints
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Amifostine Product Picture
Figure 2. Global Amifostine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Amifostine Sales Market Share by Type in 2024 & 2031
Figure 4. 400mg/Dose Product Picture
Figure 5. 500mg/Dose Product Picture
Figure 6. Global Amifostine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Amifostine Sales Market Share by Application in 2024 & 2031
Figure 8. Head and Neck Cancer Adjuvant Therapy
Figure 9. Others
Figure 10. Amifostine Report Years Considered
Figure 11. Global Amifostine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Amifostine Market Size 2020-2031 (US$ Million)
Figure 13. Global Amifostine Sales 2020-2031 (K Units)
Figure 14. Global Amifostine Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Amifostine Revenue Market Share by Region (2020-2031)
Figure 16. Global Amifostine Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Amifostine Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Amifostine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 19. Global Amifostine Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Amifostine Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Amifostine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 22. 400mg/Dose of Amifostine Revenue Market Share by Application, 2024 VS 2031
Figure 23. 500mg/Dose of Amifostine Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Amifostine Sales Share by Manufacturer in 2024
Figure 25. Amifostine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. 400mg/Dose Market Sales Proportion by Manufacturer in 2024
Figure 27. 500mg/Dose Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Amifostine Revenue 2020-2031 (US$ Million)
Figure 29. North America Amifostine Sales Market Share by Type (2020-2025)
Figure 30. North America Amifostine Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Amifostine Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Amifostine Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Amifostine Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Amifostine Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Amifostine Sales Market Share by Application (2020-2025)
Figure 36. Europe Amifostine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Amifostine Sales Market Share by Country (2020-2031)
Figure 38. Europe Amifostine Revenue Market Share by Country (2020-2031)
Figure 39. Europe Amifostine Sales Market Share by Type (2020-2025)
Figure 40. Europe Amifostine Sales Market Share by Application (2020-2025)
Figure 41. Latin America Amifostine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Amifostine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Amifostine Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Amifostine Sales Market Share by Type (2020-2025)
Figure 45. Latin America Amifostine Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Amifostine Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Amifostine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Amifostine Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Amifostine Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Amifostine Sales Market Share by Application (2020-2025)
Figure 51. Amifostine Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Amifostine Raw Materials by Region in 2024
Figure 53. Amifostine Distribution Channels
Figure 54. Global Amifostine Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Amifostine Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232